{"schema_version":"secwatch.filing_event.v1","accession":"0001489096-22-000127","form_type":"8-K","ticker":"THR","cik":"0001489096","company_name":"Thermon Group Holdings, Inc.","filed_at":"2022-09-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.901374+00:00","generated_at":"2026-06-23T15:13:45.233363+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Thermon appoints Dr. Angela Strzelecki to board of directors","bullets":["Appointed Dr. Angela Strzelecki as director effective September 6, 2022; board size increased from 7 to 8.","She currently serves as President of Pharmaceutical Solutions at IFF (NYSE:IFF) and previously held global roles at DuPont.","She will serve on the Finance, Human Capital Management and Compensation, and Nominating and Corporate Governance Committees.","Received a pro-rated annual grant of ~$6,454 in common stock under the 2020 Long-Term Incentive Plan.","Board determined she is independent under NYSE standards."],"urls":{"canonical":"https://secwatch.observer/filing/0001489096-22-000127","json":"https://secwatch.observer/filing/0001489096-22-000127.json","markdown":"https://secwatch.observer/filing/0001489096-22-000127.md","text":"https://secwatch.observer/filing/0001489096-22-000127.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1489096/000148909622000127/0001489096-22-000127-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1489096/000148909622000127/thr-20220906.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T15:13:45.233363+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cfe6975bd5","claim":"Dr. Angela Strzelecki was appointed as director at Thermon Group Holdings, Inc..","evidence_excerpt":"appointed Dr. Angela Strzelecki as a director of the Company, effective as of September 6, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1489096/000148909622000127/0001489096-22-000127-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}